Provided by Tiger Fintech (Singapore) Pte. Ltd.

Leap Therapeutics Inc

0.3172
-0.0002-0.06%
Volume:11.77K
Turnover:3.73K
Market Cap:13.14M
PE:-0.20
High:0.3198
Open:0.3180
Low:0.3100
Close:0.3174
52wk High:4.79
52wk Low:0.2223
Shares:41.44M
Float Shares:34.67M
Volume Ratio:0.28
T/O Rate:0.03%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6003
EPS(LYR):-1.8115
ROE:-183.72%
ROA:-77.23%
PB:2.30
PE(LYR):-0.18

Loading ...

Leap Therapeutics Inc. Faces Nasdaq Delisting Risk Over Stock Price Compliance

Reuters
·
Sep 12

BRIEF-Leap Therapeutics Reports Second Quarter Financial Results

Reuters
·
Aug 14

Leap Therapeutics Reports Q2 2025 Net Loss of $16.6M, Down from $20.4M in Q2 2024; R&D Expenses Decrease by $7.4M

Reuters
·
Aug 14

Leap Therapeutics Inc: Majority of These Costs Will Be Recognized in Third and Fourth Quarters of 2025

THOMSON REUTERS
·
Aug 14

Leap Therapeutics Inc: Total Costs Related to This Reduction in Force, Including Severance Payments, Are Estimated to Be About $4.5 Mln

THOMSON REUTERS
·
Aug 14

Leap Therapeutics Inc - Implements 75% Workforce Reduction

THOMSON REUTERS
·
Aug 14

Leap Therapeutics Inc expected to post a loss of 29 cents a share - Earnings Preview

Reuters
·
Aug 08

BUZZ-U.S. STOCKS ON THE MOVE-Fiserv, Eli Lilly, Nuclear stocks

Reuters
·
Jun 23

BRIEF-Leap Therapeutics Reports Updated Clinical Data From Sirexatamab Colorectal Cancer Study

Reuters
·
Jun 23

Leap Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 13

BRIEF-Leap Therapeutics Q1 Net Income USD -15.435 Million

Reuters
·
May 13

BRIEF-Leap Therapeutics - Announces 50% Workforce Reduction In Strategic Restructuring - SEC Filing

Reuters
·
May 13

Leap Therapeutics Reports Q1 2025 Net Loss of $15.4M, Up from $13.8M in Q1 2024, Due to Increased R&D Expenses

Reuters
·
May 13

Leap Therapeutics Inc expected to post a loss of 38 cents a share - Earnings Preview

Reuters
·
May 09

Leap Therapeutics Says New Data Show Sirexatamab Improves Survival in Colorectal Cancer Trial

MT Newswires Live
·
Mar 26

BRIEF-Leap Therapeutics Reports Fourth Quarter And FY 2024 Results

Reuters
·
Mar 26

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 24

Leap Therapeutics Inc expected to post a loss of 38 cents a share - Earnings Preview

Reuters
·
Mar 21

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 20